These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 27721157
1. Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease. Mishra CB, Kumari S, Manral A, Prakash A, Saini V, Lynn AM, Tiwari M. Eur J Med Chem; 2017 Jan 05; 125():736-750. PubMed ID: 27721157 [Abstract] [Full Text] [Related]
2. Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease. Mishra CB, Manral A, Kumari S, Saini V, Tiwari M. Bioorg Med Chem; 2016 Aug 15; 24(16):3829-41. PubMed ID: 27353888 [Abstract] [Full Text] [Related]
7. Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin. Yan J, Hu J, Liu A, He L, Li X, Wei H. Bioorg Med Chem; 2017 Jun 15; 25(12):2946-2955. PubMed ID: 28454848 [Abstract] [Full Text] [Related]
10. Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease. Xie SS, Lan JS, Wang X, Wang ZM, Jiang N, Li F, Wu JJ, Wang J, Kong LY. Bioorg Med Chem; 2016 Apr 01; 24(7):1528-39. PubMed ID: 26917219 [Abstract] [Full Text] [Related]
11. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties. Cai P, Fang SQ, Yang HL, Yang XL, Liu QH, Kong LY, Wang XB. Eur J Med Chem; 2018 Sep 05; 157():161-176. PubMed ID: 30096650 [Abstract] [Full Text] [Related]
12. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease. Meena P, Nemaysh V, Khatri M, Manral A, Luthra PM, Tiwari M. Bioorg Med Chem; 2015 Mar 01; 23(5):1135-48. PubMed ID: 25624107 [Abstract] [Full Text] [Related]
15. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. Li Q, He S, Chen Y, Feng F, Qu W, Sun H. Eur J Med Chem; 2018 Oct 05; 158():463-477. PubMed ID: 30243151 [Abstract] [Full Text] [Related]
16. Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease. Zhao Y, Ye F, Xu J, Liao Q, Chen L, Zhang W, Sun H, Liu W, Feng F, Qu W. Bioorg Med Chem; 2018 Jul 30; 26(13):3812-3824. PubMed ID: 29960728 [Abstract] [Full Text] [Related]
17. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH. Bioorg Med Chem; 2007 Oct 15; 15(20):6596-607. PubMed ID: 17681794 [Abstract] [Full Text] [Related]
18. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS. Int J Risk Saf Med; 2015 Oct 15; 27 Suppl 1():S69-71. PubMed ID: 26639718 [Abstract] [Full Text] [Related]